China’s National Health Commission Issues “AI + Healthcare” Implementation Opinions – Roadmap for 24 Standardized Applications
The National Health Commission (NHC) today released the Implementation Opinions on Promoting and Standardizing the...
Policy / Regulatory
Guangzhou’s 12‑Step Plan to Accelerate Innovative Drug and Device Adoption
The Guangzhou Municipal Health Commission issued a comprehensive notice detailing twelve strategic measures aimed at...
NHSA Re‑designs Drug‑Prescribing Surveillance, Targeting Illicit Use and Resale
The National Healthcare Security Administration issued a comprehensive notice to strengthen the intelligent monitoring of...
FDA Issues Draft Guidance to Accelerate Biosimilar Development and Cut Costs
The U.S. Food and Drug Administration (FDA) released a draft guidance titled “Scientific Considerations in...
FDA CDER Director George Tidmarsh Placed on Leave Amid Probe Over Drug‑Approval Program Concerns
The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) confirmed that...
MediCare Negotiation Begins: 535 Generic Drugs Reviewed for 2025 Drug Catalogue
The 2025 National Medical Insurance (MediCare) Negotiation kicked off at 8:30 AM, marking the start of...
National Health Commission Unveils Fourth Drug List for Generic Development
The National Health Commission (NHC) today released its fourth catalogue of medicines earmarked for generic...
SSY Group Limited Projected to Win 12 Products in China’s Eleventh VBP Round
China‑based SSY Group Limited (HKG: 2005) announced today that it has been pre‑selected as the...
NMPA Releases Draft Measures on Drug Quality Sampling, Seeks Public Comments by Nov 5
The National Medical Products Administration (NMPA) today issued the “Measures for the Administration of Drug...
Novartis Asciminib Enters China’s SPARK Program for Pediatric Chronic Myeloid Leukemia
The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) announced today...
NMPA Expands Reference Listed Drugs List to 98 Items for Chemical Generic Drugs
China’s National Medical Products Administration (NMPA) today released its 98th Reference Listed Drugs (RLD) list...
VBP 11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement
The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for...
Pfizer CEO Bourla Highlights Benefits of China Biotech Collaborations at NY Gala
Albert Bourla, CEO of Pfizer Inc. (NYSE: PFE), highlighted the benefits of collaborations between multinational...
National Joint Procurement Office Announces 11th Round VBP, AstraZeneca Dapagliflozin Leads Demand
On October 11, 2025, the National Joint Procurement Office (NJPO) released the full company list for...
State Council Introduces 2026 Regulations Governing Clinical Research of Biomedical New Technologies in China
The Chinese State Council has issued the Regulations on the Administration of Clinical Research and...
National Drug Alliance Moves VBP 11th‑Round Information Disclosure Conference to 27 Oct 2025 in Shanghai
The National Drug Alliance Procurement Office announced a schedule change for the 11th round of...
NMPA Announces Import of Commercial‑Scale Pre‑Approval Overseas Drugs
The National Medical Products Administration (NMPA) has issued a new regulatory framework, titled “Announcement on...
Trump’s New Pharmaceutical Tariffs Will Be Limited to 15% for EU and Japan, White House Says
A White House spokesperson clarified that President Donald Trump’s proposed tariffs on imported pharmaceuticals will not...
NHSA Launches 100‑Day Medical‑Insurance Fraud Crackdown Campaign
The National Healthcare Security Administration (NHSA) announced a nationwide 100‑Day Action aimed at eradicating illegal...